211 Stocks Hit 52-Week Highs: NBFC and Pharma Lead Price Extremes

Dec 31 2025 10:19 AM IST
share
Share Via
This monthly witnessed a pronounced divergence in sectoral price movements, with Non Banking Financial Companies (NBFCs) and Pharmaceuticals & Biotechnology sectors prominently featuring among stocks reaching new price extremes. While some sectors demonstrated resilience by hitting fresh highs, others faced considerable selling pressure, reflecting a complex market environment.



Price Extremes and Market Breadth


During this monthly, the market recorded a total of 211 stocks reaching their 52-week highs, including 32 stocks achieving all-time highs, signalling pockets of strong bullish momentum. Conversely, 926 stocks hit 52-week lows, with 13 descending to all-time lows, indicating widespread weakness. The ratio of lows to highs, nearly 2:1, underscores a prevailing selling pressure across the broader market.


Day highs and lows further illustrate intraday volatility, with 311 day highs and 103 day lows recorded. The total number of triggers, encompassing both highs and lows, stood at 1,596, reflecting active price discovery and market churn.


Large-cap stocks demonstrated relative strength, with 12 featured among the price extremes. Mid-cap and small-cap stocks were less prominent, with 6 and 2 stocks respectively making the list. This large-cap dominance aligns with the market bias observed this monthly, favouring established blue-chip companies.




Patience pays off here! This Micro Cap from Fertilizers sector has delivered steady gains quarter after quarter. Now proudly part of our Reliable Performers list.



  • - New Reliable Performer

  • - Steady quarterly gains

  • - Fertilizers consistency


Discover the Steady Winner →




Sectoral Performance Highlights


The NBFC sector led the charge among stocks hitting new highs, with 34 stocks reaching 52-week peaks. Pharmaceuticals & Biotechnology and Auto Components & Equipments sectors followed closely, each contributing 27 stocks to the highs tally. However, these sectors also appeared prominently among the stocks hitting lows, with NBFCs registering 78 stocks at 52-week lows and Pharmaceuticals & Biotechnology 53, indicating a bifurcated performance within these industries.


Garments & Apparels sector notably featured among the weakest performers, with 71 stocks hitting 52-week lows, reflecting sector-specific headwinds.



Notable Stocks Reaching Price Extremes


Among large-cap stocks, several blue-chip companies demonstrated significant price strength. Titan Company Ltd reached an all-time high, a rare milestone signalling robust investor confidence in the Gems, Jewellery and Watches sector. Vedanta Ltd, Bank Of Baroda, Mahindra & Mahindra Ltd, Eicher Motors Ltd, and Hindalco Industries Ltd all hit 52-week highs, reflecting strong momentum in metals, banking, automobiles, and non-ferrous metals sectors respectively.


Mid-cap stocks such as Muthoot Finance Ltd and National Aluminium Company Ltd also featured among the high achievers, highlighting growth potential in NBFC and metals sectors. Hero MotoCorp Ltd, a mid-cap automobile player, and Craftsman Automation Ltd, a small-cap in Auto Components & Equipments, rounded out the list of notable price strength performers.


On the downside, some large-cap stocks experienced short-term downward pressure, hitting day lows. Bank Of Baroda, Indian Oil Corporation Ltd, JSW Steel Ltd, Asian Paints Ltd, and Sun Pharmaceutical Industries Ltd were among those affected, reflecting sector-specific challenges and broader market volatility. Mid-cap and small-cap stocks such as Coforge Ltd, Hitachi Energy India Ltd, Multi Commodity Exchange of India Ltd, and Sandhar Technologies Limited also registered day lows, indicating selective profit-taking or technical corrections.



Sectoral Divergence and Market Dynamics


The coexistence of NBFCs and Pharmaceuticals & Biotechnology stocks in both high and low price extremes suggests a nuanced market environment where stock-specific factors outweigh broad sector trends. For NBFCs, regulatory developments, asset quality concerns, and credit growth prospects likely contributed to this divergence. Pharmaceuticals & Biotechnology stocks may have been influenced by pipeline developments, regulatory approvals, and global market conditions.


Large-cap strength amid overall market weakness points to investor preference for stability and liquidity during uncertain times. The presence of 32 all-time highs amidst 13 all-time lows further emphasises the market’s selective nature, rewarding companies with strong fundamentals or positive catalysts while penalising those facing structural challenges.


Compared to previous months, the elevated number of 52-week lows signals increased selling pressure, possibly linked to profit-booking, sector rotation, or macroeconomic concerns. However, the sizeable count of new highs and all-time highs indicates that pockets of opportunity remain for discerning investors.




Get the full story on ! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this . Make informed decisions!



  • - Full research story

  • - Sector comparison done

  • - Informed decision support


View Detailed Report →




Forward-Looking Considerations


Looking ahead, investors should monitor upcoming earnings announcements, regulatory updates, and sector-specific developments that could influence price trajectories. Stocks like Titan Company Ltd and Vedanta Ltd, having reached all-time or 52-week highs, will be watched closely for sustainability of momentum and potential profit-taking.


Technical levels around recent highs will serve as critical support or resistance points. For example, Mahindra & Mahindra Ltd and Eicher Motors Ltd, both automobile sector leaders, may face tests of their breakout levels amid evolving demand conditions.


Conversely, stocks that recorded day lows, such as Indian Oil Corporation Ltd and Sun Pharmaceutical Industries Ltd, may present short-term buying opportunities if fundamental catalysts emerge or if technical oversold conditions develop.


Sector rotation remains a key theme, with investors advised to assess stock-specific fundamentals within the broader context of macroeconomic trends and policy shifts. The mixed performance within NBFC and Pharmaceuticals sectors highlights the importance of selective stock picking rather than broad sector bets.


Overall, the market environment suggests cautious optimism, with pockets of strength amid broader volatility. Monitoring delivery volumes, institutional activity, and technical patterns will be essential for identifying actionable opportunities next month.






Mojo Stocks - The Top 1% Picks across Markets

Top 10 Large Cap Mid Cap Small Cap
{{col.header}}
Latest
OPEN CALL
CLOSED CALL
{{s[col.key]}} {{s.change_value}}
{{ s.score.value }} - {{ s.score.call_type }}
{{ s.dot_summary.score }} - {{ s.dot_summary.scoreText }}
{{s[col.key]}} {{col.extra}}

Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News